Clalis capsules, 50 mg, 6 -count bottle ( labeling is in foreign language)
Published March 26, 2014 · Recall initiated: June 27, 2013
Summary
FDA records drug Class I recall D-1169-2014, published March 26, 2014 and initiated June 27, 2013. Recalling firm: Fabscout Entertainment, Inc; Status: Terminated; Lot: All lots. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Marketed without an Approved NDA/ANDA: Laboratory analysis conducted by the FDA has determined that the products was found to contain sildenafil, an undeclared active pharmaceutical ingredient.
What to do
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Fabscout Entertainment, Inc
- Distributor
- Nationwide and France
- Lot
- All lots
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDASilver Sword capsules, 180 mg, 16-count clamshell tin, UPC 1 234658 970128 12345 (labeling is in foreignMarch 26, 2014
- FDAPerrigo, Clindamycin Palmitate Hydrochloride for Oral Solution, USP, 75mg/5mL, 100 ml, NDC 0574-0129-01March 26, 2014
- FDAVenlafaxine Hydrochloride, Extended Release Capsules, 150 mg, UD-100 Tablets per Box (10 x 10), Rx Only,March 26, 2014
- FDA72HP MAXIMUM POTENCY MALE SEXUAL ENHANCEMENT, Dietary Supplement, supplied in 1 capsule per blister pack,December 25, 2013
- FDAPRO POWER MAX Natural Energy Enhancer, ALL NATURAL HERBS, supplied in 1 capsule per blister pack, DistributedDecember 25, 2013
- FDAEvil Root 1200 mg, supplied in 6 capsules per bottle, Manufacturer: Tibet Shengyang Health Medicine Co.,Ltd.December 25, 2013
Questions about this recall
Was Clalis capsules, 50 mg, 6 -count bottle ( labeling is in foreign language) recalled?
Yes. FDA published recall D-1169-2014 on March 26, 2014. Reported hazard: Marketed without an Approved NDA/ANDA: Laboratory analysis conducted by the FDA has determined that the products was found to contain sildenafil, an undeclared active pharmaceutical ingredient.
What should I do if I have this product?
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit